Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130208005M |
| Application |
Infection |
The kit has been designed for the quantitative determination of Immunoglobulin G (IgG) in human serum. The method can be used for samples over the range of 0-80000 I14g/ml. The test has to be performed on the MAGLUMI chemiluminescence immunoassay (CLIA) fully auto analyzer (Including MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus).
Advanced Chemiluminescence TechnologyMAGLUMI IgG (CLIA) integrates state-of-the-art indirect chemiluminescence immunoassay technology for the precise detection of SARS-CoV-2 IgG antibodies. The assay delivers both sensitivity and specificity, ensuring dependable results that healthcare professionals can trust for patient management and epidemiological surveillance.
Rapid and High-Throughput Testing for LaboratoriesDesigned for use with the MAGLUMI Chemiluminescence Immunoassay System, this kit supports high-volume clinical settings. Its fast interpretation time of approximately 30 minutes and capacity of up to 180 tests per hour enhance laboratory workflow, enabling timely clinical decisions.
Reliable Quality and ComplianceEach MAGLUMI IgG (CLIA) kit strictly complies with international diagnostic standards. The contents-reagent kit, calibrators, controls, and comprehensive instructions-ensure consistency and reproducibility, making it a preferred choice for clinical laboratories, hospitals, and diagnostic centers across India.
FAQ's of Snibe MAGLUMI IgG (CLIA):
Q: How does the Snibe MAGLUMI IgG (CLIA) test detect SARS-CoV-2 antibodies?
A: The test uses an indirect chemiluminescence immunoassay (CLIA) principle to qualitatively detect IgG antibodies specific to SARS-CoV-2 in human serum or plasma, providing clear positive or negative results.
Q: What sample type and volume are required for this test?
A: The assay is compatible with human serum or plasma samples, requiring 10-80 L per test depending on the system settings.
Q: When and where should the reagent kit be stored?
A: To maintain optimal performance, store the kit at 2-8C in a clinical laboratory or hospital storage facility. Ensure the kit is not frozen and used within its shelf life of 12 months.
Q: What is the throughput and interpretation time for the MAGLUMI IgG (CLIA) system?
A: The MAGLUMI system can process up to 180 tests per hour, with results typically available in approximately 30 minutes, making it suitable for high-demand environments.
Q: Who can operate the Snibe MAGLUMI IgG (CLIA) assay kit?
A: Intended users include trained personnel in clinical laboratories and hospitals experienced in operating automated immunoassay analyzers.
Q: What are the key benefits of using this reagent kit?
A: The main advantages are high sensitivity and specificity, rapid turnaround time, fully automated processing, and international diagnostic standard compliance, supporting quality patient care.
Q: Is the MAGLUMI IgG (CLIA) kit compatible with other analyzers?
A: This reagent kit is specifically designed for use with the MAGLUMI Chemiluminescence Immunoassay System and may not be compatible with other analyzer brands.